Page 4 - Colin Kellaher News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Colin kellaher. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Colin Kellaher Today - Breaking & Trending Today

Lyra Therapeutics Lead Drug Candidate Fails in Phase 3 Study

By Colin Kellaher


Lyra Therapeutics on Monday said a late-stage study of its lead drug candidate missed its main goal in a chronic inflammatory sinus disorder.

Lyra said the Phase 3 study. ....

Colin Kellaher , Dow Jones ,

NextEra Energy Names New Chief Risk, Finance Officers

By Colin Kellaher


NextEra Energy has named top finance executive Kirk Crews to the newly created post of executive vice president and chief risk officer.

NextEra on Monday said Brian. ....

Colin Kellaher , Nextera Energy Partners , Nextera Energy , Goldman Sachs , Era Energy , Kirk Crews , Brian Bolster , Juno Beach , Dow Jones ,

Perficient Shares Surge Premarket on Deal to Go Private

By Colin Kellaher


Shares of Perficient jumped nearly 55% in premarket trading Monday after the digital consultancy agreed to be acquired by Swedish private-equity firm EQT AB at an enterprise. ....

Colin Kellaher , Dow Jones ,

Pfizer Names Andrew Baum Chief Strategy, Innovation Officer

By Colin Kellaher


Pfizer had hired Andrew Baum as the drugmaker s next chief strategy and innovation officer.

Pfizer on Monday said Baum, who has been Citi s head of global healthcare and. ....

New York , United States , Albert Bourla , Aamir Malik , Colin Kellaher , Andrew Baum , Morgan Stanley , Dow Jones ,

FTC Seeks More Info On $16.5 Billion Novo/Catalent Deal

By Colin Kellaher


A $16.5 billion deal aimed at boosting Novo Nordisk s production of the weight-loss drug Wegovy is drawing extra scrutiny from U.S. antitrust regulators.

Novo Holdings,. ....

Colin Kellaher , Exchange Commission On , Capri Holdings , Novo Holdings , Novo Nordisk , Exchange Commission , Federal Trade Commission , Dow Jones ,